Business Case Studies, Diversification Strategies Case Study, Novo Nordisk,Danish Pharmaceutical Company's

print page
Tell A Friend
Bookmark
 

Case Categories

Diversification Strategies Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Novo Nordisk: The Danish Pharmaceutical Company's Diversification Strategies

Publication Year : 2005

Authors: Novo Nordisk: The Danish Pharmaceutical Company's Diversification Strategies

Industry: Health Care

Region:Denmark

Case Code: DIS0009

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
Novo Nordisk from Denmark is the world's leading insulin maker with a global market share of 50%. Along with diabetes care it also operates in biopharmaceutical segments like haemostasis management and growth hormone therapy. However, with increasing competition from Eli Lilly, Pfizer and Sanofi-Aventis in its core business of anti-diabetes drugs, Novo Nordisk has diversified into other areas like oncology and analgesics.

Pedagogical Objectives:

  • To highlight the diversification strategies of Novo Nordisk
  • To discuss Novo Nordisk's ability to successfully enter new therapeutic areas, where it lacks core competency.

Keywords : Competition in global anti-diabetic market; Eli Lilly; Pfizer; GlaxoSmithKline; Research and development expenditure by pharmaceutical companies; Sanofi-Aventis; Haemostasis management; Diversification Strategies Case Study; Growth hormone therapy; Anti-diabetes care; Biopharmaceuticals; Non-steroidal anti-inflammatory drugs; Diversification of global pharmaceutical companies

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap